Management of Fever in Neonates and Children
Neonates ≤28 Days: Full Septic Workup Required
All febrile neonates ≤28 days require immediate hospital admission, complete septic evaluation (blood, urine, and cerebrospinal fluid cultures), and empiric intravenous antibiotics regardless of appearance 1, 2. This age group has a 13% risk of serious bacterial infection (SBI) and only 58% of those with bacteremia or meningitis appear clinically ill 3.
Immediate Actions for Neonates:
- Obtain blood culture, urinalysis with culture (catheterized specimen), and lumbar puncture
- Administer empiric antibiotics immediately: Ampicillin IV/IM (150 mg/kg/day divided every 8h for UTI; 300 mg/kg/day divided every 6h for meningitis) PLUS either ceftazidime IV/IM (150 mg/kg/day divided every 8h) OR gentamicin IV/IM (4 mg/kg every 24h) 1
- Admit to hospital for observation pending culture results
- Temperature >40°C in this age group carries an odds ratio of 6.3 for severe bacterial infection 4
Critical pitfall: Clinical appearance is unreliable in neonates—even well-appearing infants can have life-threatening infections 2. Never discharge a febrile neonate without full evaluation.
Young Infants 29-60 Days: Risk-Stratified Approach
For infants 29-60 days, management depends on clinical appearance, laboratory markers, and viral testing results 1. The 2021 AAP guidelines provide the most current evidence-based framework.
Age 29-60 Days Evaluation Algorithm:
Step 1: Assess Clinical Appearance
- If ill-appearing: Treat as neonate (full septic workup + empiric antibiotics + admission)
- If well-appearing: Proceed to risk stratification
Step 2: Obtain Laboratory Studies
- Blood culture
- Urinalysis and urine culture (catheterized specimen)
- Consider inflammatory markers (CBC, procalcitonin, CRP)
- Viral testing (respiratory panel, enterovirus PCR if available)
Step 3: Risk Stratification Based on Results
For infants 29-60 days:
- Normal CSF, normal urinalysis, abnormal inflammatory markers: May administer parenteral antibiotics in hospital 1
- Documented viral illness with normal urinalysis: Lumbar puncture may be deferred, but close follow-up mandatory (return visit or admission) 3
- Any abnormal urinalysis: Treat for UTI with ceftriaxone 50 mg/kg IV/IM once daily 1
Important nuance: Viral co-infection does NOT exclude bacterial infection—approximately 10% of SBIs occur with documented viral illness 5. Urinalysis should remain routine regardless of viral testing results.
Age-Specific Antibiotic Regimens (29-60 days):
- UTI: Ceftriaxone 50 mg/kg IV/IM once daily
- No focus identified: Ceftriaxone 50 mg/kg IV/IM once daily
- Bacterial meningitis: Ceftriaxone 100 mg/kg/day IV (once daily or divided every 12h) OR ceftazidime 150 mg/kg/day divided every 8h PLUS vancomycin 60 mg/kg/day divided every 8h 1
Older Infants and Children 2-24 Months: Focused Evaluation
For well-appearing children 2-24 months, evaluation should target urinary tract infection as the most common SBI in the post-pneumococcal vaccine era 3. E. coli now accounts for 87.4% of UTIs and 60% of bacteremia in this age group.
Key Clinical Predictors:
- UTI risk factors: Female sex (8-9% prevalence), uncircumcised males <1 year (3-4% prevalence), fever ≥39°C, fever duration >24 hours 3
- Pneumonia indicators: High fever (≥40°C), cough, rales/crackles, tachypnea, tachycardia, decreased breath sounds 3
Management Approach:
- Urinalysis mandatory for high-risk patients (young females, uncircumcised males, fever >39°C without source)
- Chest radiograph only if respiratory symptoms present—not routinely indicated 3
- Blood cultures rarely indicated in well-appearing, fully immunized children (occult bacteremia rate <1% post-vaccine era) 3
- Lumbar puncture NOT routinely needed unless meningeal signs present
Outpatient management acceptable for well-appearing children with:
- Normal urinalysis
- No respiratory distress
- Reliable caregiver with ability to return in 12-24 hours
- Access to follow-up care
Antipyretic Use: Symptom-Based Only
Antipyretic medications should be given ONLY to reduce suffering and impairment, not routinely to lower temperature 4. Fever itself is a normal defense mechanism.
When Antipyretics Are Indicated:
- Child demonstrates significant discomfort or distress
- Impaired ability to eat, drink, or sleep
Dosing:
- Acetaminophen: 10-15 mg/kg per dose, maximum 4 times daily
- Ibuprofen: 10 mg/kg per dose, maximum 3 times daily 4
Do not alternate or combine antipyretics—no evidence of benefit and increases risk of dosing errors.
Critical Red Flags Requiring Immediate Evaluation
Parents must be educated to recognize warning signs:
- Impaired consciousness or lethargy
- Petechiae or purpura (cutaneous hemorrhage)
- Signs of dehydration (decreased urine output, dry mucous membranes)
- Capillary refill time >3 seconds
- Inconsolable crying or irritability
- Poor feeding in infants 4
Temperature measurement: Rectal digital thermometry is gold standard for infants <3 months (sensitivity/specificity >95%). Infrared tympanic thermometry acceptable from age 1 year onward (sensitivity 77%, specificity 98%) 4.
Key Practice Points
- Age <28 days = automatic admission + full septic workup + antibiotics—no exceptions
- Age 29-60 days = risk stratification possible but requires careful laboratory evaluation and reliable follow-up
- Viral testing does not exclude bacterial infection—maintain high index of suspicion
- UTI is now the most common SBI in the post-vaccine era—urinalysis is essential
- Clinical appearance alone is insufficient to exclude serious infection, especially in neonates
- Shared decision-making with families is appropriate for borderline cases in 29-60 day age group, but must include discussion of risks and need for close follow-up 1